Phase IIB Study of Recombinant Novel Coronavirus Vaccine
NCT05293223
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class
Conditions
COVID-19 Vaccine
Interventions
BIOLOGICAL:
Ad5-nCov
Sponsor
Fundación Huésped
Collaborators
[object Object]
[object Object]